Drugs / Sprintec
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SPRINTEC | — | 2002-09-25 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00130117 Background | Apr 2010 → Aug 2011 | amenorrhea | Beth Israel Deaconess Medical Center | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sprintec | “Sprintec taken orally once daily.” NCT00130117 ↗ |
| Route | Oral | “Sprintec taken orally once daily.” NCT00130117 ↗ |